로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Protein > Claudin-18.2 > CL2-H82P3

Biotinylated Human Claudin-18.2 Protein (VLP)

Order Now

  • Synonym
    Claudin-18.2,CLDN18,Claudin-18
  • Source
    Biotinylated Human Claudin-18.2 Protein (VLP)(CL2-H82P3) is expressed from human 293 cells (HEK293). It contains AA Lys 25 - Asp 184 (Accession # P56856-2 ).
    Predicted N-terminus: Lys 25
  • Molecular Characterization

    Virus-like particles(VLPs) are formed by self-assembly of capsid proteins from viruses. Membrane Proteins can be constituted in-situ with VLPs produced from HEK293 cell cultures. These VLPs concentrate conformationally intact membrane proteins directly on the cell surface and produce soluble, high-concentration proteins perfect for immunization and antibody screening.

    The VLPs provide the display of properly folded membrane proteins in their native cellular membrane in a compact size of 100~300 nm diameter (similar to the size of most viruses) making it optimal targets for dendritic cells in vivo and surface attachment for phage display.

  • Labeling
    The VLP is biotinylated with propriety technology.
  • Protein Ratio
    Passed as determined by the HABA assay / binding ELISA.
  • Purity

    >95% as determined by SEC-HPLC.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
*The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow this link for product information.
SEC-HPLC
Claudin-18.2 SEC-HPLC

The purity of Biotinylated Human Claudin-18.2 Protein (VLP) (Cat. No. CL2-H82P3) was greater than 95% as determined by SEC-HPLC.

Bioactivity-ELISA
 Claudin-18.2 ELISA

Immobilized Biotinylated Human Claudin-18.2 Protein (VLP) (Cat. No. CL2-H82P3) at 5 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-Claudin-18.2 antibody with a linear range of 0.05-2 ng/mL (QC tested).

 Claudin-18.2 ELISA

ELISA comparison of biotinylated human Claudin-18.2 (virus-like particles) using anti-Claudin-18.2 antibody shows ACRO (Cat. No. CL2-H82P3) has superior bioactivity to Company K (Routinely tested).

Bioactivity-SPR
 Claudin-18.2 SPR

Biotinylated Human Claudin-18.2 Protein (VLP) (Cat. No. CL2-H82P3) immobilized on SA Chip can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with an affinity constant of 0.601 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Identity-DLS
 Claudin-18.2 DLS

The mean peak Radius of VLP is 60-85 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

  • Background
    Involved in alveolar fluid homeostasis via regulation of alveolar epithelial tight junction composition and therefore ion transport and solute permeability, potentially via downstream regulation of the actin cytoskeleton organization and beta-2-adrenergic signaling. Required for lung alveolarization and maintenance of the paracellular alveolar epithelial barrier. Acts to maintain epithelial progenitor cell proliferation and organ size, via regulation of YAP1 localization away from the nucleus and thereby restriction of YAP1 target gene transcription. Acts as a negative regulator of RANKL-induced osteoclast differentiation, potentially via relocation of TJP2/ZO-2 away from the nucleus, subsequently involved in bone resorption in response to calcium deficiency. Mediates the osteoprotective effects of estrogen, potentially via acting downstream of estrogen signaling independently of RANKL signaling pathways. Required for the formation of the gastric paracellular barrier via its role in tight junction formation, thereby involved in the response to gastric acidification.
  • Clinical and Translational Updates

Comments (0)


ETA of in-stock products: 2 business days

Recommended Products
Streptavidin Coated Plates

Price(USD) : $32.00

Price(USD) : $137.00

Streptavidin-HRP

Price(USD) : $50.00

Price(USD) : $120.00

Magnetic Beads™ Streptavidin

Price(USD) : $138.00

Price(USD) : $230.00

Drug Candidate Licensing

more

Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:62 Details
  • Latest Research Phase:NDA/BLA

Datasheet & Documentation

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop